Bruker (BRKR) — insider trading
Health Care
Bruker (BRKR) has 18 reported SEC Form 4 insider transactions in our data, including 4 open-market sales among the most recent 18 (latest 2026-06-15).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Munch Mark | Officer (EXEC VP&PRES BRUKER NANO INC.) | Option exercise / conversion (derivative) | 2,000 | $0.00 | $0 | Form 4 |
| 2026-06-15 | Munch Mark | Officer (EXEC VP&PRES BRUKER NANO INC.) | Open-market sale | 2,000 | $54.76 | $109.5K | Form 4 |
| 2026-06-15 | Munch Mark | Officer (EXEC VP&PRES BRUKER NANO INC.) | Option exercise / conversion | 2,000 | $22.19 | $44.4K | Form 4 |
| 2026-05-15 | Bernard Thierry | Director | Grant / award / vesting | 2,886 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Munch Mark | Officer (EXEC VP&PRES BRUKER NANO INC.) | Option exercise / conversion (derivative) | 2,000 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Munch Mark | Officer (EXEC VP&PRES BRUKER NANO INC.) | Open-market sale | 2,000 | $43.90 | $87.8K | Form 4 |
| 2026-05-15 | Munch Mark | Officer (EXEC VP&PRES BRUKER NANO INC.) | Option exercise / conversion | 2,000 | $22.19 | $44.4K | Form 4 |
| 2026-04-15 | Munch Mark | Officer (EXEC VP&PRES BRUKER NANO INC.) | Option exercise / conversion (derivative) | 2,000 | $0.00 | $0 | Form 4 |
| 2026-04-15 | Munch Mark | Officer (EXEC VP&PRES BRUKER NANO INC.) | Open-market sale | 2,000 | $39.90 | $79.8K | Form 4 |
| 2026-04-15 | Munch Mark | Officer (EXEC VP&PRES BRUKER NANO INC.) | Option exercise / conversion | 2,000 | $22.19 | $44.4K | Form 4 |
| 2026-03-13 | Munch Mark | Officer (EXEC VP&PRES BRUKER NANO INC.) | Option exercise / conversion (derivative) | 2,000 | $0.00 | $0 | Form 4 |
| 2026-03-13 | Munch Mark | Officer (EXEC VP&PRES BRUKER NANO INC.) | Open-market sale | 2,000 | $35.44 | $70.9K | Form 4 |
| 2026-03-13 | Munch Mark | Officer (EXEC VP&PRES BRUKER NANO INC.) | Option exercise / conversion | 2,000 | $22.19 | $44.4K | Form 4 |
| 2026-02-15 | Perkins Adelene Q | Director | Grant / award / vesting | 4,520 | $0.00 | $0 | Form 4 |
| 2026-02-15 | LINTON WILLIAM A | Director | Grant / award / vesting | 4,520 | $0.00 | $0 | Form 4 |
| 2026-02-15 | ORNELL JOHN A | Director | Grant / award / vesting | 4,520 | $0.00 | $0 | Form 4 |
| 2026-02-15 | Phillips Jack | Director | Grant / award / vesting | 4,520 | $0.00 | $0 | Form 4 |
| 2026-02-15 | FRANCIS LAURA | Director | Grant / award / vesting | 4,520 | $0.00 | $0 | Form 4 |
Ask the chat about BRKR's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Bruker (BRKR).
Last updated 2026-06-15 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.